Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H8BrO4.Na |
| Molecular Weight | 307.073 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].COC1=CC=C(C=C1)C(=O)C(\Br)=C/C([O-])=O
InChI
InChIKey=DVDCIQWIGOVWEX-MLBSPLJJSA-M
InChI=1S/C11H9BrO4.Na/c1-16-8-4-2-7(3-5-8)11(15)9(12)6-10(13)14;/h2-6H,1H3,(H,13,14);/q;+1/p-1/b9-6+;
| Molecular Formula | Na |
| Molecular Weight | 22.9898 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C11H8BrO4 |
| Molecular Weight | 284.083 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Bromebric Acid (Cytembena) is a derivative of bromoacrylic acid with cytostatic and antineoplastic activity. Chemical structure of Bromebric Acid is not related to any previous antineoplastic agent. In animal tumor screens, Jelinek and Semonsky noted antineoplastic activity of Cytembena against sarcoma 180, atlenocarcinoina of the lactic gland in mice, Ehrlich’s ascitic carcinoma, Yoshida’s ascitic sarcoma, and Zojdeln’s heap
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:25:19 GMT 2023
by
admin
on
Sat Dec 16 09:25:19 GMT 2023
|
| Record UNII |
9V238C7BMX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C272
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID40273998
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
21739-91-3
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
9V238C7BMX
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
23665583
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
100000092633
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
C1360
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | NCIT | ||
|
4134
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
16170-75-5
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
104801
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY | |||
|
SUB26045
Created by
admin on Sat Dec 16 09:25:19 GMT 2023 , Edited by admin on Sat Dec 16 09:25:19 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |